Department of Public Health, China Medical University, Taichung, Taiwan, ROC; Department of Respiratory Therapy, China Medical University Hospital, China Medical University, Taichung, Taiwan, ROC.
Department of Healthcare Administration, Asia University, Taichung, Taiwan, ROC; Department of Medical Research, China Medical University Hospital, China Medical University, Taichung, Taiwan, ROC.
Health Policy. 2018 Sep;122(9):970-976. doi: 10.1016/j.healthpol.2018.07.009. Epub 2018 Jul 19.
An integrated delivery system with a prospective payment program (IPP) for prolonged mechanical ventilation (PMV) was launched by Taiwan's National Health Insurance (NHI) due to the costly and limited ICU resources. This study aimed to analyze the effectiveness of IPP and evaluate the factors associated with successful weaning and survival among patients with PMV.
Taiwan's NHI Research Database was searched to obtain the data of patients aged ≥17 years who had PMV from 2006 to 2010 (N=50,570). A 1:1 propensity score matching approach was used to compare patients with and without IPP (N=30,576). Cox proportional hazards modeling was used to examine the factors related to successful weaning and survival.
The related factors of lower weaning rate in IPP participants (hazard ratio [HR]=0.84), were older age, higher income, catastrophic illness (HR=0.87), and higher comorbidity. The effectiveness of IPP intervention for the PMV patients showed longer days of hospitalization, longer ventilation days, higher survival rate, and higher medical costs (in respiratory care center, respiratory care ward). The 6-month mortality rate was lower (34.0% vs. 32.9%). The death risk of IPP patients compared to those non-IPP patients was lower (HR=0.91, P<0.001).
The policy of IPP for PMV patients showed higher survival rate although it was costly and related to lower weaning rate.
由于昂贵且有限的 ICU 资源,台湾全民健康保险推出了一种带前瞻性支付计划(IPP)的综合交付系统,用于治疗长时间机械通气(PMV)患者。本研究旨在分析 IPP 的效果,并评估与 PMV 患者成功脱机和存活相关的因素。
本研究通过台湾全民健康保险研究数据库,获取了 2006 年至 2010 年间年龄≥17 岁、患有 PMV 的患者数据(N=50570)。采用 1:1 倾向评分匹配方法比较了有和没有 IPP 的患者(N=30576)。采用 Cox 比例风险模型来检验与成功脱机和存活相关的因素。
IPP 参与者的较低脱机率相关因素(风险比[HR]=0.84)为年龄较大、收入较高、灾难性疾病(HR=0.87)和较高的合并症。IPP 干预 PMV 患者的效果表现为住院天数更长、通气天数更长、生存率更高和医疗费用更高(在呼吸治疗中心和呼吸治疗病房)。6 个月死亡率较低(34.0%比 32.9%)。与非 IPP 患者相比,IPP 患者的死亡风险较低(HR=0.91,P<0.001)。
尽管昂贵且与较低脱机率相关,但 PMV 患者的 IPP 政策显示出较高的生存率。